|
Therapeutic targets of cancer drugs: Modulation by melatonin
|
26 November 2021 |
|
Multiple interactions between melatonin and non-coding RNAs in cancer biology
|
26 November 2021 |
|
Modulation of the tumor microenvironment (TME) by melatonin
|
25 November 2021 |
|
Inhibition of angiogenesis by S-adenosylmethionine
|
23 November 2021 |
|
Total Vitamin D Intake and Risks of Early-Onset Colorectal Cancer and Precursors
|
19 November 2021 |
|
SSTR2 is a prognostic factor and a promising therapeutic target in glioma
|
19 November 2021 |
|
Parameters of Oxidative Stress, Vitamin D, Osteopontin, and Melatonin in Patients with Lip, Oral Cavity, and Pharyngeal Cancer
|
19 November 2021 |
|
MTNR1B polymorphisms with CDKN2A and MGMT methylation status are associated with poor prognosis of colorectal cancer in Taiwan
|
19 November 2021 |
|
Vitamin D and Gastric Cancer: A Ray of Sunshine?
|
16 November 2021 |
|
Treatment of Platelet Deficiency in a Cohort of Patients by a Combination of Melatonin and 5-Methoxytryptamine
|
12 November 2021 |